VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 111 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $278 | -99.6% | 24,321 | +125.5% | 0.00% | +100.0% |
| Q2 2022 | $64,000 | -46.2% | 10,787 | -30.8% | 0.00% | -50.0% |
| Q1 2022 | $119,000 | -18.5% | 15,590 | -55.9% | 0.00% | 0.0% |
| Q2 2021 | $146,000 | +67.8% | 35,328 | +189.5% | 0.00% | +100.0% |
| Q4 2020 | $87,000 | -58.4% | 12,205 | -37.6% | 0.00% | -75.0% |
| Q3 2020 | $209,000 | -60.3% | 19,556 | -53.1% | 0.00% | -71.4% |
| Q2 2020 | $526,000 | +239.4% | 41,716 | +275.8% | 0.01% | +366.7% |
| Q4 2019 | $155,000 | – | 11,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |